Scientific Reports (Jul 2017)
Distribution and genotype-phenotype correlation of GDAP1 mutations in Spain
- Rafael Sivera,
- Marina Frasquet,
- Vincenzo Lupo,
- Tania García-Sobrino,
- Patricia Blanco-Arias,
- Julio Pardo,
- Roberto Fernández-Torrón,
- Adolfo López de Munain,
- Celedonio Márquez-Infante,
- Liliana Villarreal,
- Pilar Carbonell,
- Ricard Rojas-García,
- Sonia Segovia,
- Isabel Illa,
- Anna Lia Frongia,
- Andrés Nascimento,
- Carlos Ortez,
- María del Mar García-Romero,
- Samuel Ignacio Pascual,
- Ana Lara Pelayo-Negro,
- José Berciano,
- Antonio Guerrero,
- Carlos Casasnovas,
- Ana Camacho,
- Jesús Esteban,
- María José Chumillas,
- Marisa Barreiro,
- Carmen Díaz,
- Francesc Palau,
- Juan Jesús Vílchez,
- Carmen Espinós,
- Teresa Sevilla
Affiliations
- Rafael Sivera
- Department of Neurology, Hospital Francesc de Borja
- Marina Frasquet
- Department of Neurology, Hospital Universitari i Politécnic La Fe
- Vincenzo Lupo
- Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders and Service of Genomics and Traslational Geneticis, Centro de Investigación Príncipe Felipe (CIPF)
- Tania García-Sobrino
- Department of Neurology, Hospital Clínico
- Patricia Blanco-Arias
- Neurogenetics Research Group, Instituto de Investigaciones Sanitarias (IDIS)
- Julio Pardo
- Department of Neurology, Hospital Clínico
- Roberto Fernández-Torrón
- Neuromuscular Disorders Unit, Neurology Department, Hospital Donostia
- Adolfo López de Munain
- Neuromuscular Disorders Unit, Neurology Department, Hospital Donostia
- Celedonio Márquez-Infante
- Department of Neurology and Neurophysiology, Hospital Universitario Virgen del Rocío
- Liliana Villarreal
- Department of Neurology and Neurophysiology, Hospital Universitario Virgen del Rocío
- Pilar Carbonell
- Department of Neurology and Neurophysiology, Hospital Universitario Virgen del Rocío
- Ricard Rojas-García
- Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Intituto Carlos III, Ministry of Economy and Competitiviness
- Sonia Segovia
- Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Intituto Carlos III, Ministry of Economy and Competitiviness
- Isabel Illa
- Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Intituto Carlos III, Ministry of Economy and Competitiviness
- Anna Lia Frongia
- Neuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, Fundacion Sant Joan de Deu
- Andrés Nascimento
- Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Intituto Carlos III, Ministry of Economy and Competitiviness
- Carlos Ortez
- Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Intituto Carlos III, Ministry of Economy and Competitiviness
- María del Mar García-Romero
- Neuropaediatrics Department, Hospital la Paz
- Samuel Ignacio Pascual
- Neuropaediatrics Department, Hospital la Paz
- Ana Lara Pelayo-Negro
- Center for Biomedical Research in the Neurodegenerative Diseases (CIBERNED) Network, Instituto Carlos III, Ministry of Economy and Competitiviness
- José Berciano
- Center for Biomedical Research in the Neurodegenerative Diseases (CIBERNED) Network, Instituto Carlos III, Ministry of Economy and Competitiviness
- Antonio Guerrero
- Neuromuscular Diseases Unit, Department of Neurology, Hospital Clínico San Carlos
- Carlos Casasnovas
- Neuromuscular Diseases Unit, Department of Neurology, Hospital Universitari de Bellvitge – IDIBELL
- Ana Camacho
- Child Neurology Unit, Department of Neurology, Hospital Universitario 12 de Octubre
- Jesús Esteban
- Department of Neurology, Hospital Universitario 12 de Octubre
- María José Chumillas
- Department of Neurophysiology, Hospital Universitari I Politécnic La Fe
- Marisa Barreiro
- Neuromuscular Research Unit, Instituto de Investigación Sanitaria la Fe (IIS La Fe)
- Carmen Díaz
- Department of Neurology, Hospital General de Alicante
- Francesc Palau
- Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Intituto Carlos III, Ministry of Economy and Competitiviness
- Juan Jesús Vílchez
- Department of Neurology, Hospital Universitari i Politécnic La Fe
- Carmen Espinós
- Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders and Service of Genomics and Traslational Geneticis, Centro de Investigación Príncipe Felipe (CIPF)
- Teresa Sevilla
- Department of Neurology, Hospital Universitari i Politécnic La Fe
- DOI
- https://doi.org/10.1038/s41598-017-06894-6
- Journal volume & issue
-
Vol. 7,
no. 1
pp. 1 – 10
Abstract
Abstract Mutations in the GDAP1 gene can cause Charcot-Marie-Tooth disease. These mutations are quite rare in most Western countries but not so in certain regions of Spain or other Mediterranean countries. This cross-sectional retrospective multicenter study analyzed the clinical and genetic characteristics of patients with GDAP1 mutations across Spain. 99 patients were identified, which were distributed across most of Spain, but especially in the Northwest and Mediterranean regions. The most common genotypes were p.R120W (in 81% of patients with autosomal dominant inheritance) and p.Q163X (in 73% of autosomal recessive patients). Patients with recessively inherited mutations had a more severe phenotype, and certain clinical features, like dysphonia or respiratory dysfunction, were exclusively detected in this group. Dominantly inherited mutations had prominent clinical variability regarding severity, including 29% of patients who were asymptomatic. There were minor clinical differences between patients harboring specific mutations but not when grouped according to localization or type of mutation. This is the largest clinical series to date of patients with GDAP1 mutations, and it contributes to define the genetic distribution and genotype-phenotype correlation in this rare form of CMT.